A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

Clinical trial NCT07545772 · RECRUITING

Trial details

NCT number: NCT07545772
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Constipation

Start date: 2026-04-29
Primary completion: 2027-07-01
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.